|
|
||||||||
1 Department of Physiology, Temple University School of Medicine, Philadelphia, Pennsylvania 19140; and 2 Department of Physiology and Biophysics, Albert Einstein College of Medicine, Bronx, New York 10461
To examine the relationship between
mitochondrial NADH (NADHm) and cardiac work output,
NADHm and the amplitude and frequency of the contractile
response of electrically paced rat heart cells were measured at 25°C.
With 5.4 mM glucose plus 2 mM
-hydroxybutyrate, NADHm was reversibly decreased by 23%, and the amplitude
of contraction was reversibly decreased by 27% during 4-Hz pacing.
With glucose plus 2 mM pyruvate or with 10 mM
2-deoxy-D-glucose, NADHm was maintained during
rapid pacing, and the contractile amplitude remained high.
Phosphocreatine levels decreased with 2-deoxy-D-glucose administration but not with rapid pacing. Respiration increased to meet
the increased ATP demand at 30°C. The data suggest that 1)
when NADHm is decreased during rapid pacing with defined
substrates, the amplitude of contraction is decreased; 2)
the amplitude of contraction during electrical pacing does not change
with rate of pacing when both the ATP and NADHm levels are
continuously replenished; and 3) the replenishment of
NADHm during pacing with physiological substrates may be
rate-limited by substrate supply to mitochondrial dehydrogenases.
During activation of mitochondrial dehydrogenases, or a significant
increase in free ADP induced by 2-deoxy-D-glucose,
this rate limitation is bypassed or overcome.
restwork transition; steady-state adenosine 5'-triphosphate utilization; substrate supply; phosphocreatine; lactate; 2-deoxy-D-glucose; reduced nicotinamide adenine dinucleotide; reduced nicotinamide adenine dinucleotide phosphate
This article has been cited by other articles:
![]() |
B. Korzeniewski Oxygen consumption and metabolite concentrations during transitions between different work intensities in heart Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1466 - H1474. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P. Grazette, W. Boecker, T. Matsui, M. Semigran, T. L. Force, R. J. Hajjar, and A. Rosenzweig Inhibition of ErbB2 causes mitochondrial dysfunction in cardiomyocytes: Implications for herceptin-induced cardiomyopathy J. Am. Coll. Cardiol., December 7, 2004; 44(11): 2231 - 2238. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |